Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Disodium uridine-5'-monophosphate is a nucleotide that serves as a key component of ribonucleic acid (RNA). It is naturally present in RNA-rich foods and is also available as a dietary supplement. Research has indicated that Disodium uridine-5'-monophosphate can enhance cognitive function in animals.

3387-36-8

Post Buying Request

3387-36-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3387-36-8 Usage

Uses

Used in Dietary Supplements:
Disodium uridine-5'-monophosphate is used as a dietary supplement to support cognitive function and overall brain health due to its role in RNA synthesis and its potential to improve cognitive performance in animals.
Used in Scientific Research:
In the field of scientific research, disodium uridine-5'-monophosphate serves as a valuable tool for studying the effects of pyrimidine synthesis inhibitors, such as 5-azacytidine, on cholesterol and lipid metabolism. This helps researchers understand the underlying mechanisms and potential therapeutic applications in various health conditions.
Used in Microbiology:
Disodium uridine-5'-monophosphate is also utilized in microbiology to investigate the impact of nucleotides on the growth of specific intestinal bacteria. This research can contribute to a better understanding of the role of nucleotides in gut health and the development of probiotics or other treatments targeting intestinal microbiota.

Check Digit Verification of cas no

The CAS Registry Mumber 3387-36-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,3,8 and 7 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 3387-36:
(6*3)+(5*3)+(4*8)+(3*7)+(2*3)+(1*6)=98
98 % 10 = 8
So 3387-36-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/p-2/t4-,6-,7-,8-/m1/s1

3387-36-8 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (U0021)  Uridine 5'-Monophosphate Disodium Salt Hydrate  >98.0%(HPLC)

  • 3387-36-8

  • 5g

  • 590.00CNY

  • Detail
  • TCI America

  • (U0021)  Uridine 5'-Monophosphate Disodium Salt Hydrate  >98.0%(HPLC)

  • 3387-36-8

  • 25g

  • 1,890.00CNY

  • Detail
  • Alfa Aesar

  • (A18601)  Uridine-5'-monophosphate disodium salt, 99%   

  • 3387-36-8

  • 5g

  • 618.0CNY

  • Detail
  • Alfa Aesar

  • (A18601)  Uridine-5'-monophosphate disodium salt, 99%   

  • 3387-36-8

  • 25g

  • 2732.0CNY

  • Detail
  • Alfa Aesar

  • (A18601)  Uridine-5'-monophosphate disodium salt, 99%   

  • 3387-36-8

  • 100g

  • 8983.0CNY

  • Detail
  • USP

  • (1222400)  Disodium 5′-uridylate  United States Pharmacopeia (USP) Reference Standard

  • 3387-36-8

  • 1222400-500MG

  • 4,326.66CNY

  • Detail

3387-36-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Disodium uridine-5'-monophosphate

1.2 Other means of identification

Product number -
Other names Uridine 5‘-monophosphate,disodium salt,hydrate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3387-36-8 SDS

3387-36-8Synthetic route

uridine 5'-(5-dimethylaminoisoquinolin-1-yl)methylphosphate

uridine 5'-(5-dimethylaminoisoquinolin-1-yl)methylphosphate

A

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

B

5-dimethylamino-1-hydroxymethylisoquinoline
75795-45-8

5-dimethylamino-1-hydroxymethylisoquinoline

Conditions
ConditionsYield
With snake venom phosphodiesterase for 3h; enzymatic hydrolysis; var.: pH;
uridine 5'-(5-dimethylamino-2-oxidoisoquinolin-1-yl)methylphosphate

uridine 5'-(5-dimethylamino-2-oxidoisoquinolin-1-yl)methylphosphate

A

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

B

5-dimethylamino-1-hydroxymethylisoquinolin-2-oxide
75795-49-2

5-dimethylamino-1-hydroxymethylisoquinolin-2-oxide

Conditions
ConditionsYield
With sodium acetate; snake venom phosphodiesterase at 37℃; for 3h; enzymatic hydrolysis, pH=8; half-life=7 h (pH=4.1), 12 h (pH=10.1), 24 h (pH=7.1), T=37 deg C;
orotic acid sodium salt
154-85-8

orotic acid sodium salt

5-phospho-D-ribosyl α-1-pyrophosphate
87372-47-2, 94902-32-6, 108321-05-7, 129136-58-9

5-phospho-D-ribosyl α-1-pyrophosphate

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Conditions
ConditionsYield
With DL-dithiothreitol; magnesium chloride for 192h; PAN-immobilized O-5-decarboxylase, O-5-P-pyrophosphorylase, PPiase; Yield given;
uridine
58-96-8

uridine

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Conditions
ConditionsYield
Multistep reaction.;
orotidine 5‘-monophosphate trisodium salt

orotidine 5‘-monophosphate trisodium salt

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Conditions
ConditionsYield
With ODCase from Methanobacterium thermoautotrophicum In various solvent(s) at 55℃; pH=7.5; Enzyme kinetics; Further Variations:; Temperatures;
With orotidine 5'-monophosphate decarboxylase mutant Q215A/Y217F/R235A In aq. buffer at 25℃; pH=7.1; Kinetics; Reagent/catalyst; Enzymatic reaction;
Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: Na2ATP, MgCl2*6H2O, PEP-K+, DTT, K2HPO4, Na2EDTA / 72 h / PAN-immobilized pyruvate kinase, adenylate kinase, PRPP synthetase, pH 7.5
2: MgCl2*6H2O, DTT / 192 h / PAN-immobilized O-5-decarboxylase, O-5-P-pyrophosphorylase, PPiase
View Scheme
α,β-D-ribofuranose-5-phophate disodium salt
108321-99-9, 150713-51-2

α,β-D-ribofuranose-5-phophate disodium salt

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 70 mmol / Na2ATP, MgCl2*6H2O, PEP-K+, K2HPOu, Na2EDTA / 96 h / 30 °C / immobilized PRPP synthetase, pyruvate kinase, adenylate kinase, pH 7.4
2: MgCl2*6H2O, DTT / 192 h / PAN-immobilized O-5-decarboxylase, O-5-P-pyrophosphorylase, PPiase
View Scheme
adenosine-5'-monophosphate disodium salt
4578-31-8

adenosine-5'-monophosphate disodium salt

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 94 percent / Dowex 50 W-X8 (H+ form) / H2O / 0.14 h / Heating
2: 70 mmol / Na2ATP, MgCl2*6H2O, PEP-K+, K2HPOu, Na2EDTA / 96 h / 30 °C / immobilized PRPP synthetase, pyruvate kinase, adenylate kinase, pH 7.4
3: MgCl2*6H2O, DTT / 192 h / PAN-immobilized O-5-decarboxylase, O-5-P-pyrophosphorylase, PPiase
View Scheme
C9H13N3O11P2(2-)*2Na(1+)

C9H13N3O11P2(2-)*2Na(1+)

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Conditions
ConditionsYield
With water; zinc(II) cation pH=5.5;
tributyl-amine
102-82-9

tributyl-amine

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

uridine 5′-monophosphate tributylammonium salt

uridine 5′-monophosphate tributylammonium salt

Conditions
ConditionsYield
Stage #1: disodium uridine-5'-monophosphate With DOWEX IR100S resin In water Industrial scale;
Stage #2: tributyl-amine In water at 15 - 25℃; pH=6.5 - 7.5; Industrial scale;
91.4%
With DOWEX IR100S resin In water at 15 - 25℃; pH=6.5 - 7.5; Industrial scale;91.4%
With DOWEX 50WX2-200 (H)
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

acetic anhydride
108-24-7

acetic anhydride

tributylammonium 2',3'-di-O-acetyluridine 5'-monophosphate
79744-04-0, 89681-69-6

tributylammonium 2',3'-di-O-acetyluridine 5'-monophosphate

Conditions
ConditionsYield
In pyridine; N,N-dimethyl-formamide72%
copper(II) nitrate trihydrate

copper(II) nitrate trihydrate

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

water
7732-18-5

water

4-pyridinealdazine
6957-22-8

4-pyridinealdazine

[Cu2(uridine 5'-monophosphate)2(1,4-bis(4-pyridyl)-2,3-diaza-1,3-butadiene)2(H2O)3]*10H2O

[Cu2(uridine 5'-monophosphate)2(1,4-bis(4-pyridyl)-2,3-diaza-1,3-butadiene)2(H2O)3]*10H2O

Conditions
ConditionsYield
In ethanol for 0.5h;68%
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

thioacetic acid
507-09-5

thioacetic acid

2′,3′-di-O-acetyl β-uridine-5′-phosphate
48215-95-8

2′,3′-di-O-acetyl β-uridine-5′-phosphate

Conditions
ConditionsYield
With propiolonitrile; sodium hydroxide In water; water-d2 pH=8;67%
copper(II) nitrate trihydrate

copper(II) nitrate trihydrate

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

water
7732-18-5

water

trans-1,2-bis(4-pyridyl)ethylene
1135-32-6

trans-1,2-bis(4-pyridyl)ethylene

[Cu2(uridine 5'-monophosphate)2(1,2-bis(4-pyridyl)ethylene)2(H2O)2]*7H2O

[Cu2(uridine 5'-monophosphate)2(1,2-bis(4-pyridyl)ethylene)2(H2O)2]*7H2O

Conditions
ConditionsYield
In ethanol for 0.5h;63%
2-chloro-1,3-dimethyl imidazolium chloride

2-chloro-1,3-dimethyl imidazolium chloride

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

A

1,3-dimethyl-2-imidazolidinone
80-73-9

1,3-dimethyl-2-imidazolidinone

B

Up2U
26184-65-6

Up2U

Conditions
ConditionsYield
at 37℃; for 24h;A 40%
B n/a
α-2-azido-2-deoxy-3,4,6-tri-O-acetyl-D-galactose 1-phosphate
1608127-23-6

α-2-azido-2-deoxy-3,4,6-tri-O-acetyl-D-galactose 1-phosphate

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

C21H27N5O19P2(2-)

C21H27N5O19P2(2-)

Conditions
ConditionsYield
Stage #1: disodium uridine-5'-monophosphate In water for 0.5h;
Stage #2: With tributyl-amine In water at 20℃; for 0.5h;
Stage #3: α-2-azido-2-deoxy-3,4,6-tri-O-acetyl-D-galactose-1-phosphate Further stages;
37%
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

methyl iodide
74-88-4

methyl iodide

A

3'-O-methyluridine 5'-monophosphate
69113-66-2

3'-O-methyluridine 5'-monophosphate

B

2',3'-di-O-methyluridine 5'-monophosphate
142657-17-8

2',3'-di-O-methyluridine 5'-monophosphate

C

2'-O-methyluridine 5'-monophosphate monosodium salt
142657-18-9

2'-O-methyluridine 5'-monophosphate monosodium salt

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane for 3h; Ambient temperature; various alkyl iodides, other temperature;A 11%
B 33%
C 20%
With sodium hydroxide In 1,4-dioxane for 3h; Ambient temperature;A 11%
B 33%
C 20%
[Cu4(μ-OH)(μ-(α-D-glycopyranose-1-phosphate)2(2,2'-bipyridyl)4(H2O)2]Cl3*14H2O

[Cu4(μ-OH)(μ-(α-D-glycopyranose-1-phosphate)2(2,2'-bipyridyl)4(H2O)2]Cl3*14H2O

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

water
7732-18-5

water

[Cu(μ-(uridine 5'-monophosphate-H))(2,2'-bipyridine)(H2O)]2[Cu4(μ-OH)(μ-(α-D-Glc-1P))2(bpy)4(H2O)2]Cl*9H2O

[Cu(μ-(uridine 5'-monophosphate-H))(2,2'-bipyridine)(H2O)]2[Cu4(μ-OH)(μ-(α-D-Glc-1P))2(bpy)4(H2O)2]Cl*9H2O

Conditions
ConditionsYield
In water uridine 5'-monophosphate disodium salt (0.076 mmol) added to aq. soln. of Cu complex (0.059 mmol); stirred (12 h); concd. (vac.); concd. slowly; crystals collected; dried (vac.); elem. anal.;30%
2-azido-2-deoxy-α-D-galactofuranosyl phosphate triethylammonium salt

2-azido-2-deoxy-α-D-galactofuranosyl phosphate triethylammonium salt

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

UDP-2-azido-2-deoxy-α-D-galactofuranose triethylammonium salt

UDP-2-azido-2-deoxy-α-D-galactofuranose triethylammonium salt

Conditions
ConditionsYield
Stage #1: disodium uridine-5'-monophosphate With 1H-imidazole; 2-chloro-1,3-dimethylimidazolinium chloride In water-d2 at 37℃; for 1h; Inert atmosphere;
Stage #2: 2-azido-2-deoxy-α-D-galactofuranosyl phosphate triethylammonium salt In water-d2 at 37℃; for 18h; Inert atmosphere;
Stage #3: With calf intestinal alkaline phosphatase In water-d2 at 30℃; for 24h; pH=8; Inert atmosphere; Enzymatic reaction;
23%
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

ethyl iodide
75-03-6

ethyl iodide

A

3'-O-ethyluridine 5'-monophosphate
51785-61-6

3'-O-ethyluridine 5'-monophosphate

B

2'-O-ethyluridine 5'-monophosphate
50582-57-5

2'-O-ethyluridine 5'-monophosphate

C

2',3'-di-O-ethyluridine 5'-monophosphate disodium salt
142657-19-0

2',3'-di-O-ethyluridine 5'-monophosphate disodium salt

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 65℃; for 3h;A 22%
B 18%
C 18%
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Sucrose
57-50-1

Sucrose

UDP-glucose
133-89-1

UDP-glucose

Conditions
ConditionsYield
With bovine serum albumine; phospho(enol)pyruvate CHA-salt; tris hydrochloride; uridine 5'-triphosphate trisodium salt; magnesium chloride; diothiothreitol at 30℃; for 21h; sucrose synthase, pyruvate kinase, nucleoside monophosphate kinase;21%
2-acetamido-2-deoxy-α-D-galactofuranosyl phosphate triethylammonium salt

2-acetamido-2-deoxy-α-D-galactofuranosyl phosphate triethylammonium salt

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

UDP-2-acetamido-2-deoxy-α-D-galactofuranose triethylammonium salt

UDP-2-acetamido-2-deoxy-α-D-galactofuranose triethylammonium salt

Conditions
ConditionsYield
Stage #1: disodium uridine-5'-monophosphate With 1H-imidazole; 2-chloro-1,3-dimethylimidazolinium chloride In water-d2 at 37℃; for 1h; pH=8; Inert atmosphere;
Stage #2: 2-acetamido-2-deoxy-α-D-galactofuranosyl phosphate triethylammonium salt In water-d2 at 37℃; for 24h; Inert atmosphere;
Stage #3: With calf intestinal alkaline phosphatase In water-d2 at 30℃; for 24h; pH=8; Inert atmosphere; Enzymatic reaction;
16%
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

1-iodo-propane
107-08-4

1-iodo-propane

A

2'-O-n-propyluridine 5'-monophosphate
142657-21-4

2'-O-n-propyluridine 5'-monophosphate

B

2',3'-di-O-n-propyluridine 5'-monophosphate monosodium salt
142657-20-3

2',3'-di-O-n-propyluridine 5'-monophosphate monosodium salt

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 70℃; for 3h;A 13%
B 13%
2-iodo-propane
75-30-9

2-iodo-propane

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

A

3'-O-isopropyluridine 5'-monophosphate monosodium salt
142657-23-6

3'-O-isopropyluridine 5'-monophosphate monosodium salt

B

uridine 5'-monophosphate isopropyl ester monosodium salt
142657-22-5

uridine 5'-monophosphate isopropyl ester monosodium salt

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 70℃; for 3h;A 9%
B 10%
1-nitro-3-vinyl-benzene
586-39-0

1-nitro-3-vinyl-benzene

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

5(E)-(3-nitrostyryl)uridine 5'-phosphate
72045-18-2

5(E)-(3-nitrostyryl)uridine 5'-phosphate

Conditions
ConditionsYield
With lithium pentachloropalladate; mercury(II) diacetate 1) water, 50 deg C, 5 h; 2) methanol, 30 min; Yield given. Multistep reaction;
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

[(1S)-2-imidazol-1-yl-1-methyl-2-oxo-ethyl]-carbamic acid tert-butyl ester
54430-64-7, 86194-94-7, 92008-48-5

[(1S)-2-imidazol-1-yl-1-methyl-2-oxo-ethyl]-carbamic acid tert-butyl ester

A

C17H24N3O12P(2-)*2Na(1+)

C17H24N3O12P(2-)*2Na(1+)

B

C17H24N3O12P(2-)*2Na(1+)

C17H24N3O12P(2-)*2Na(1+)

Conditions
ConditionsYield
In water at 20 - 22℃; for 2.5h; various nucleoside 5'-phosphates, syntheses of 2'(3')-O-aminoacylnucleosides;
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

5-dimethylamino-2-oxidoisoquinolin-1-yl diazomethane
75795-52-7

5-dimethylamino-2-oxidoisoquinolin-1-yl diazomethane

uridine 5'-(5-dimethylamino-2-oxidoisoquinolin-1-yl)methylphosphate

uridine 5'-(5-dimethylamino-2-oxidoisoquinolin-1-yl)methylphosphate

Conditions
ConditionsYield
In water for 0.333333h; Ambient temperature; pH=5 (HCl);
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

acetic anhydride
108-24-7

acetic anhydride

Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-(acetoxy-hydroxy-phosphoryloxymethyl)-2-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester

Acetic acid (2R,3R,4R,5R)-4-acetoxy-5-(acetoxy-hydroxy-phosphoryloxymethyl)-2-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester

Conditions
ConditionsYield
With pyridine In N,N-dimethyl-formamide for 24h; Ambient temperature;
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

chlorophosphoric acid diphenyl ester
2524-64-3

chlorophosphoric acid diphenyl ester

uridine 5'-(diphenyl diphosphate)
32452-87-2

uridine 5'-(diphenyl diphosphate)

Conditions
ConditionsYield
With tributyl-amine In 1,4-dioxane; N,N-dimethyl-formamide
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Acetic acid (1S,2S,3R,5S,6R)-2,6-diacetoxy-3-acetoxymethyl-5-phosphonooxy-cyclohexyl ester

Acetic acid (1S,2S,3R,5S,6R)-2,6-diacetoxy-3-acetoxymethyl-5-phosphonooxy-cyclohexyl ester

C24H34N2O20P2

C24H34N2O20P2

Conditions
ConditionsYield
With 1,1'-carbonyldiimidazole 1.) acetone, 18 h, room temp., 2.) DMF, 18 h, room temp.; Multistep reaction;
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

Acetic acid (2R,3R,4R,5R,6R)-3-acetoxy-2-acetoxymethyl-5-(2-azido-acetylamino)-6-phosphonooxy-tetrahydro-pyran-4-yl ester

Acetic acid (2R,3R,4R,5R,6R)-3-acetoxy-2-acetoxymethyl-5-(2-azido-acetylamino)-6-phosphonooxy-tetrahydro-pyran-4-yl ester

C23H32N6O20P2

C23H32N6O20P2

Conditions
ConditionsYield
With triethylamine In acetonitrile at 0℃; for 3h;
disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

pyrenyl-1-diazomethane
78377-23-8

pyrenyl-1-diazomethane

1-pyrenylmethyl uridine-5'-phosphate

1-pyrenylmethyl uridine-5'-phosphate

Conditions
ConditionsYield
With boric acid In ethyl acetate; acetonitrile at 60℃;
1-methyl-1H-imidazole
616-47-7

1-methyl-1H-imidazole

disodium uridine-5'-monophosphate
3387-36-8

disodium uridine-5'-monophosphate

trifluoroacetic anhydride
407-25-0

trifluoroacetic anhydride

UMP-N-methylimidazolide

UMP-N-methylimidazolide

Conditions
ConditionsYield
Stage #1: disodium uridine-5'-monophosphate; trifluoroacetic anhydride With triethylamine In acetonitrile at 0 - 20℃;
Stage #2: 1-methyl-1H-imidazole With triethylamine In acetonitrile at 0℃; for 0.166667h;

3387-36-8Relevant articles and documents

Enzyme architecture: Deconstruction of the enzyme-activating phosphodianion interactions of orotidine 5′-monophosphate decarboxylase

Goldman, Lawrence M.,Amyes, Tina L.,Goryanova, Bogdana,Gerlt, John A.,Richard, John P.

, p. 10156 - 10165 (2014)

The mechanism for activation of orotidine 5′-monophosphate decarboxylase (OMPDC) by interactions of side chains from Gln215 and Try217 at a gripper loop and R235, adjacent to this loop, with the phosphodianion of OMP was probed by determining the kinetic parameters kcat and K m for all combinations of single, double, and triple Q215A, Y217F, and R235A mutations. The 12 kcal/mol intrinsic binding energy of the phosphodianion is shown to be equal to the sum of the binding energies of the side chains of R235 (6 kcal/mol), Q215 (2 kcal/mol), Y217 (2 kcal/mol), and hydrogen bonds to the G234 and R235 backbone amides (2 kcal/mol). Analysis of a triple mutant cube shows small (ca. 1 kcal/mol) interactions between phosphodianion gripper side chains, which are consistent with steric crowding of the side chains around the phosphodianion at wild-type OMPDC. These mutations result in the same change in the activation barrier to the OMPDC-catalyzed reactions of the whole substrate OMP and the substrate pieces (1-β-d-erythrofuranosyl)orotic acid (EO) and phosphite dianion. This shows that the transition states for these reactions are stabilized by similar interactions with the protein catalyst. The 12 kcal/mol intrinsic phosphodianion binding energy of OMP is divided between the 8 kcal/mol of binding energy, which is utilized to drive a thermodynamically unfavorable conformational change of the free enzyme, resulting in an increase in (kcat)obs for OMPDC-catalyzed decarboxylation of OMP, and the 4 kcal/mol of binding energy, which is utilized to stabilize the Michaelis complex, resulting in a decrease in (Km)obs.

Phosphorylation, oligomerization and self-assembly in water under potential prebiotic conditions

Gibard, Clémentine,Bhowmik, Subhendu,Karki, Megha,Kim, Eun-Kyong,Krishnamurthy, Ramanarayanan

, p. 212 - 217 (2018)

Prebiotic phosphorylation of (pre)biological substrates under aqueous conditions is a critical step in the origins of life. Previous investigations have had limited success and/or require unique environments that are incompatible with subsequent generation of the corresponding oligomers or higher-order structures. Here, we demonstrate that diamidophosphate (DAP) - a plausible prebiotic agent produced from trimetaphosphate - efficiently (amido)phosphorylates a wide variety of (pre)biological building blocks (nucleosides/tides, amino acids and lipid precursors) under aqueous (solution/paste) conditions, without the need for a condensing agent. Significantly, higher-order structures (oligonucleotides, peptides and liposomes) are formed under the same phosphorylation reaction conditions. This plausible prebiotic phosphorylation process under similar reaction conditions could enable the systems chemistry of the three classes of (pre)biologically relevant molecules and their oligomers, in a single-pot aqueous environment.

5’-Phosphorylation Increases the Efficacy of Nucleoside Inhibitors of the DNA Repair Enzyme SNM1A

Berney, Mark,Fay, Ellen M.,Manoj, Manav T,McGouran, Joanna F.

supporting information, (2022/01/13)

Certain cancers exhibit upregulation of DNA interstrand crosslink repair pathways, which contributes to resistance to crosslinking chemotherapy drugs and poor prognoses. Inhibition of enzymes implicated in interstrand crosslink repair is therefore a promising strategy for improving the efficacy of cancer treatment. One such target enzyme is SNM1A, a zinc co-ordinating 5’–3’ exonuclease. Previous studies have demonstrated the feasibility of inhibiting SNM1A using modified nucleosides appended with zinc-binding groups. In this work, we sought to develop more effective SNM1A inhibitors by exploiting interactions with the phosphate-binding pocket adjacent to the enzyme's active site, in addition to the catalytic zinc ions. A series of nucleoside derivatives bearing phosphate moieties at the 5’-position, as well as zinc-binding groups at the 3’-position, were prepared and tested in gel-electrophoresis and real-time fluorescence assays. As well as investigating novel zinc-binding groups, we found that incorporation of a 5’-phosphate dramatically increased the potency of the inhibitors.

Design of inhibitors of orotidine monophosphate decarboxylase using bioisosteric replacement and determination of inhibition kinetics

Poduch, Ewa,Bello, Angelica M.,Tang, Sishi,Fujihashi, Masahiro,Pai, Emil F.,Kotra, Lakshmi P.

, p. 4937 - 4945 (2007/10/03)

Inhibitors of orotidine monophosphate decarboxylase (ODCase) have applications in RNA viral, parasitic, and other infectious diseases. ODCase catalyzes the decarboxylation of orotidine monophosphate (OMP), producing uridine monophosphate (UMP). Novel inhibitors 6-amino-UMP and 6-cyano-UMP were designed on the basis of the substructure volumes in the substrate OMP and in an inhibitor of ODCase, barbituric acid monophosphate, BMP. A new enzyme assay method using isothermal titration calorimetry (ITC) was developed to investigate the inhibition kinetics of ODCase. The reaction rates were measured by monitoring the heat generated during the decarboxylation reaction of orotidine monophosphate. Kinetic parameters (kcat = 21 s-1 and KM = 5 μM) and the molar enthalpy (ΔHapp = 5 kcal/mol) were determined for the decarboxylation of the substrate by ODCase. Competitive inhibition of the enzyme was observed and the inhibition constants (Ki) were determined to be 12.4 μm and 29 μM for 6-aza-UMP and 6-cyano-UMP, respectively. 6-Amino-UMP was found to be among the potent inhibitors of ODCase, having an inhibition constant of 840 nM. We reveal here the first inhibitors of ODCase designed by the principles of bioisosterism and a novel method of using isothermal calorimetry for enzyme inhibition studies.

A solid phase reagent for the capture phosphorylation of carbohydrates and nucleosides.

Parang,Fournier,Hindsgaul

, p. 307 - 309 (2007/10/03)

[figure: see text] A 1% cross-linked divinylbenzene-polystyrene copolymer, containing cyanoethoxy N,N-diisopropylamine phosphine was prepared as a phosphitylating agent. The polymer-bound phosphitylated precursor was subjected to reaction with alcohols in the presence of 1H-tetrazole to produce the corresponding polymer-bound phosphite triesters. These were then oxidized with tert-butyl hydroperoxide to give the polymer-bound monophosphate triesters. Removal of cyanoethoxy on the resin with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) followed by basic cleavage of the p-hydroxybenzyl linker products yielded monophosphate derivatives.

Practical Synthesis of 5-Phospho-D-ribosyl α-1-pyrophosphate (PRPP): Enzymatic Routes from Ribose 5-Phosphate or Ribose

Gross, Akiva,Abril, Obsidiana,Lewis Jerome M.,Geresh, Shimona,Whitesides, George M.

, p. 7428 - 7435 (2007/10/02)

This paper describes enzymatic syntheses of 5-phospho-D-ribosyl α-1-pyrophosphate (PRPP) on a 75-mmol scale.The reactions used PAN-immobilized PRPP synthetase as catalyst with in situ ATP-cofactor regeneration.In one procedure pure r-5-P was used as a starting material; in a second, r-5-P was synthesized by ribokinase-catalyzed phosphorilation of D-ribose and used in situ.The potential for use of PRPP as a starting material for the preparation of nucleotides was demonstrated by an enzymatic synthesis of UMP.This paper also describes several methods for the preparation of r-5-P: acid-catalyzed hydrolysis of AMP, acid-catalyzed hydrolysis of crude mononucleotide mixture obtained by digestion of RNA, chemical synthesis from D-ribose, and ribokinase-catalyzed synthesis from D-ribose.Procedures are described for the isolation of PRPP synthetase (from Salmonella typhimurium) and ribokinase (from Lactobacillus plantarum) and for immobilization of these enzymes in PAN.

SYNTHETIC NUCLEOSIDES AND NUCLEOTIDES. XV. 5-DIMETHYLAMINO-2-OXIDOISOQUINOLIN-1-YL DIAZOMETHANE: A NOVEL WATER-SOLUBLE FLUORESCENT LABELLING AGENT FOR NUCLEOTIDES

Nishimura, Shigeko,Saneyoshi, Mineo

, p. 1695 - 1703 (2007/10/02)

A novel fluorescent labelling agent, 5-dimethylamino-2-oxidoisoquinolin-1-yl diazomethane (3) was designed and synthesized for the fluorescent labelling of the phosphate moiety of nucleotides and nucleic acids.Starting from 1-cyano-5-nitroisoquinoline (4), 1-carboxy-5-nitroisoquinoline (5) was obtained after hydrolysis with hydrochloric acid.Esterification of 5 with methanol in the presence of sulfuric acid afforded 1-methoxycarbonyl-5-nitroisoquinoline (6).Catalytic hydrogenation of 6 followed by treatment with formic acid-acetic anhydride gave the 5-formamido derivative (8).Methylation of 8 with methyl iodide in the presence of sodiu m hydride afforded the 5-N-methylformamido derivative (9).Reduction of both the ester group and formyl group with aluminum hydride followed by treatment with chloranil and acetic anhydride provided 1-acetoxymethyl-5-dimethylaminoisoquinoline (11).N-Oxidation of 11 with m-chloroperbenzoic acid followed by selective removal of the oxido group at the 5-position by reaction with carbon disulfide afforded 1-acetoxymethyl-5-dimethylaminoisoquinoline-2-oxide (13).After deacylation of 13, selenium dioxide oxidation of the hydroxymethyl group followed by reaction with p-toluenesulfonyl hydrazide gave 5-dimethylamino-1-formylisoquinoline-2-oxide p-toluenesulfonyl hydrazone (16).On treatment of 16 with sodium ethoxide, the desired compound (3) was obtained.Reaction of 3 with p-nitrobenzoic acid gave the crystalline p-nitrobenzoyl ester.Treatment of uridine 5'-phosphate with 3 gave uridine 5'-(5-dimethylamino-2-oxidoisoquinolin-1-yl)methylphosphate (17).This labelled nucleotide was highly fluorescent, with an excitation maximum of 353 nm and an emission maximum at 523 nm.The fluorescence characteristics of 17 were compared with those of the model compound (13) and uridine 5'-(5-dimethylaminoisoquinolin-1-yl) methylphosphate (18).Keywords- fluorescent labelling agent; fluorescent labelling of nucleotides; 5-dimethylamino-2-oxidoisoquinolin-1-yl diazomethane; synthesis; reaction with uridine 5'-phosphate; fluorescence properties;uridine 5'-(5-dimethylaminoisoquinolin-1-yl)methylphosphate; uridine 5'-(5-dimethylamino-2-oxidoisoquinolin-1-yl)methylphosphate

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3387-36-8